CFDE Data Portal | Search SUGT1P1

	Label	Description
	SUGT1P1 associations Collection (Entity type)	Associations for SUGT1P1_associations
	SUGT1P1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	SUGT1P1 Gene (Entity type)	ENSG00000228072 - SUGT1 pseudogene 1
	GSE198930 prunetin AGS 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE176008 pyridoxine 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE111247 temozolomide LN-308 14 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE179235 MEK NRAS inhibition 0 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE218060 decitabine T cell 7 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE126651 PRMT5 MTAP inhibition 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE218060 decitabine T cell 2 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS

SUGT1P1 associations

Associations for SUGT1P1_associations

SUGT1P1 associations.tsv

A file from IDG as part of the Harmonizome project

SUGT1P1

ENSG00000228072 - SUGT1 pseudogene 1

GSE198930 prunetin AGS 1 v 0 human dn

A Gene Set from LINCS

GSE176008 pyridoxine 0 v 1 human dn

A Gene Set from LINCS

GSE111247 temozolomide LN-308 14 v 10 human dn

A Gene Set from LINCS

GSE179235 MEK NRAS inhibition 0 v 3 human dn

A Gene Set from LINCS

GSE218060 decitabine T cell 7 v 0 human dn

A Gene Set from LINCS

GSE126651 PRMT5 MTAP inhibition 1 v 2 human dn

A Gene Set from LINCS

GSE218060 decitabine T cell 2 v 4 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.